![Ted Yednock](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ted Yednock
Technik-/Wissenschafts-/F&E-Leiter bei
ANNEXON, INC.
Vermögen: 1 Mio $ am 31.05.2026
Profil
Ted Yednock is currently Chief Innovation Officer & Executive VP at Annexon, Inc. since 2021, with employment at Annexon, Inc. starting in 2013.
Formerly, Dr. Yednock was Executive Vice President & Head-Global Research at Elan Corp.
Plc from 2005 to 2014, Scientist at Athena Neurosciences LLC from 1990 to 1996, Head-Global Research at Elan Pharmaceuticals LLC from 1996 to 2013, and Chief Scientific Officer at Prothena Corp.
Plc.
Education includes an undergraduate degree from the University of Illinois conferred in 1979 and a doctorate from The University of California, San Francisco conferred in 1986.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ANNEXON, INC. 0.11% | 11.06.2026 | 184’807 ( 0.11% ) | 1 Mio $ | 31.05.2026 |
Aktive Positionen von Ted Yednock
| Unternehmen | Position | Beginn |
|---|---|---|
| ANNEXON, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2013 |
Ehemalige bekannte Positionen von Ted Yednock
| Unternehmen | Position | Ende |
|---|---|---|
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Technik-/Wissenschafts-/F&E-Leiter | 24.04.2014 |
Elan Pharmaceuticals LLC
 Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | 01.01.2013 |
Athena Neurosciences LLC
 Athena Neurosciences LLC Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic products | Corporate Officer/Principal | 01.01.1996 |
| PROTHENA CORPORATION PLC | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Ted Yednock
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
75
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Athena Neurosciences LLC
Athena Neurosciences LLC Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic products | Commercial Services |
Elan Pharmaceuticals LLC
Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Annexon, Inc.
 Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prothena Corp. Plc
 Prothena Corp. Plc BiotechnologyHealth Technology Focuses on the discovery and development of novel antibodies | Health Technology |
Wählen Sie MarketScreener 
